Sex hormones are associated with the physiology and pathophysiology of almost all organs in body, as well as most diseases. Interest in the associations between sex hormones and ocular tissues has increased in recent years. Androgens may have a positive effect on dry eye, whereas the effects of estrogen on ocular conditions remain unclear. Intracrinology, the local synthesis and metabolism of hormones which is unique to humans, is of relevance to the eye and may help to explain why studies of the relationship between estrogens and dry eye signs and symptoms are inconclusive.
I. INTRODUCTION: SEX AND DRY EYE

Epidemiology
Approximately 3.2 million women and 1.68 million men in the United States suffer from severe dry eye symptoms or clinically diagnosed dry eye, with millions more experiencing less intense symptoms. [1, 2] Large epidemiological studies have identified female sex and older age as risk factors for the development of dry eye. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The risk of experiencing dry eye appears to increase over two times with menopause.
[11]
Pathophysiology
Dry eye occurs when the tear film is compromised, either by reduced aqueous production or increased evaporation: tear quality and stability is thus impaired. The pathogenesis of dry eye is complex and as yet not completely understood. Its aetiology is multifactorial; in addition to inflammatory processes and neural feedback mechanisms, there is also strong evidence for a hormone-mediated contribution. [9, 12] 
Treatment of dry eye
Medications, such as anti-inflammatory and anti-biotic agents, can be used for treating processes involved in dry eye, including reducing the presence of inflammatory mediators or pathogens on the ocular surface. [13] However, many traditional treatments for dry eye disease are only palliative, including artificial lubricants or retention plugs, aimed at increasing the volume of tears on the ocular surface. A treatment directed at the underlying cause has the potential to provide effective relief to the millions of people worldwide who suffer from dry eye disease; this is not currently possible due to the current uncertainty of the pathophysiology of dry eye.
Sex-related differences
Sex-related differences are found in almost every cell and tissue in the body, thus it is rational to expect that sex-differences also occur in ocular tissues. [14] Vernal keratoconjunctivitis (VKC) is a well-documented example of an ocular surface disease which shows significant sex-related prevalence, with over three quarters of patients being male. [15] VKC also shows a tendency to resolve around puberty, in both males and females, which suggests a hormonal effect on VKC. [15] In addition, the number of estrogen and progesterone receptors in the epithelium and sub epithelium of the tarsal and bulbar conjunctiva has been shown to increase with disease duration, which suggests a possible relationship between these hormones and VKC. [16] This review examines the mechanisms of steroidal sex hormone biosynthesis and considers the implications of local hormone production on investigations of hormone effects on dry eye.
II. SEX HORMONES
Sex hormones, including androgens and estrogens, are steroids responsible for some of the most profound changes which occur to the body. Sex hormones are associated with the physiology and pathophysiology of almost all organs, as well as most diseases. Figure 1 shows the steroidogenic pathways.
Sex hormone biosynthesis
Synthesis of circulating sex hormones
Androgens and estrogens are biologically active in both sexes and it is erroneous to associate estrogens with female and androgens exclusively with male sex. In men the testes provide a near continuous supply of androgens and small amounts of estrogens through a male's lifetime. [17] In women the ovaries secrete estrogens, progesterone and androgens. However at menopause ovarian secretion of estrogen and progesterone stops. [18] Women undergo a slow decline in testosterone with age, which doesn't appear to be associated with the final menstrual period. [19] In adult men, blood testosterone levels are 100-150x the level of estradiol. [20] In premenopausal adult women, during the early follicular phase of the menstrual cycle (when estrogen and progesterone levels are low), circulating testosterone levels are 2-3x that of estradiol, with the ratio increasing post-menopause (>5years) to 80 times the level of estradiol.
[21]
Intracrinology: Synthesis of sex hormones in peripheral tissue
As well as being secreted by the gonads and adrenals, sex hormones are produced in peripheral tissues throughout the body from circulating precursors of adrenal or gonadal origin. [22] Intracrinology was pioneered as a new branch of endocrinology by Ferdinand Labrie, in the late 1980's, describing the mechanisms of the synthesis of active hormones in peripheral tissues from DHEA and its sulfate DHEA-S ( see FIG 1) .
During intracrinology, hormones exert their action within the same cells in which they are synthesized and in which they are metabolized before being released into circulation as inactive compounds. [22] The intracellular inactivation of sex hormones prior to release into extracellular space protects neighbouring tissues from the action of sex hormone thus avoiding possible adverse effects of their systemic circulation. [23] A key difference between endocrinology and intracrinology is that endocrine organs, such as the ovaries, disperse synthesized sex hormones via general circulation to all bodily tissues. Conversely, intracrinology allows individual tissues to synthesize the required amount of estrogens and androgens without releasing significant amounts of biologically active hormones into circulation. [24, 25] As the only animal species with adrenals that secrete large amounts of DHEA and dehydroepiandrosterone sulfate (DHEA-S), humans and other primates are unique in their ability to produce hormones locally. [23] DHEA and DHEA-S are received by the local cells from circulation then converted into androstenedione (4-dione) and subsequently into androgens and estrogens (FIG 1) [26] at levels required by the specific cells. [24] There is an abundance of DHEA in serum, with serum levels of DHEA being about 10 times higher than testosterone levels, and 500 times higher than estradiol levels. [27] In humans, DHEA levels in circulation reach maximum levels between age 20-30 years, decreasing by 80% by the age of 70 in males and females. [28] , [29] This great reduction in adrenal secretion of DHEA and DHEA-S results in a large fall in the formation of androgens and estrogens in peripheral tissues with age. [30] If tear producing tissues are presumed to produce sex hormones locally by intracrinology, this drop in DHEA and DHEA-S could be a contributing factor to the increase of dry eye with age. [3] Celec describes DHEA as a "human molecule" because levels in humans are so much higher than in animal species. [31] The adrenals of rats and other animals do not secrete significant amounts of DHEA required for synthesis of sex hormones by intracrinology. [32] Consequently rodents, who secrete sex steroids solely from the gonads, are very different to humans. Hence as animals lack the ability to make hormones locally, caution should be taken when applying rodent/animal models to human models. As a result, this review focusses on human studies.
III. SIGNIFICANCE OF INTRACRINOLOGY
Measuring testosterone and DHT concentrations in serum indicates testicular function, in men, or ovarian function, in women, and does not include local intracrine production.
Almost all androgens in women are made in peripheral tissues. The total androgen pool in both men and women can be better estimated by the serum concentrations of androgen metabolites: androsterone glucuronide (ADT-G), 3α-diol-G and 3β-diol-G. [33] In men it is estimated that 30-50% of total androgens are synthesized locally from inactive adrenal precursors. [34] Using the sum of these androgen metabolites in blood, androgen production in post-menopausal women has been calculated to be over two thirds of that of men, much higher than previously thought, [35] yet their serum testosterone concentration is only 3% that of men (15ng/dL in women, 461ng/dL in men). [20, 21] Therefore, measuring metabolite levels rather than levels of active androgens provides a more accurate indication of the amount of active androgens within peripheral tissues.
Estrogens produced by intracrine processes are also important. Labrie estimates that pre-menopause, 75% of estrogens are made in peripheral tissues by intracrinology, with this increasing to 100% after menopause (as depicted in Figure 2 ). [22, 26, 33] Although the percentage of estrogens being produced by intracrinology increases postmenopause, the total estrogen produced is lower compared with pre-menopause where there are both endocrine and intracrine sources. To achieve a better estimation of the amount of estrogens in the human body many published studies measure estrogen metabolites. These include, but are not limited to, hydroxylated metabolites such as 2-hydroxyestrone, 2-hydroxyestradiol, 16α-hydroxyestrone and estriol [36] or sulphated metabolites. [37] Intracrine synthesis of sex hormones is vital for maintaining normal function in humans. Peripheral tissues require access to high circulating levels of DHEA and to intracrine enzymes, including aromatase, 5α-reductase, 17β-HSD and 3β-HSD, to enable biosynthesis of estrogens and/or androgens. [33, 38] All human tissues, except the endometrium, possess these enzymes (reviewed by Labrie) [24] thus intracrinology allows circulating levels of estrogens to remain sub threshold post-menopause. This avoids stimulation of the endometrium, whilst allowing tissues to create their own estrogens as needed.
Sex hormones and the ocular surface
Human ocular surface tissues, like other peripheral tissues, are thought to make sex hormones at levels required by each tissue, by intracrine processes. [22] It is proposed that circulating sex hormones and metabolites are supplied to, and removed from, the ocular surface in a similar way to other nutrients: via diffusion into and from the tear fluid, and blood vessels in the conjunctiva and other ocular tissues. During intracrinology, these sex hormones are used within the cells in which they are synthesised, with minimal release of active hormone out of the tissue. The metabolites are then released into circulation and may also be released into the tears. 
Steroidogenic enzymes in human ocular surface tissues
The transformation of adrenal precursor steroids, DHEA and DHEA-S, into androgens or estrogens relies on the expression of steroidogenic enzymes in peripheral tissues. [30] Steroid sulfatase, aromatase, glucuronosyltransferase, 3β-HSD-∆-5∆4-isomerase type 1, 17β-HSD types 1 and 3, and 5α-reductase types 1 and 2 are all required for the conversion of DHEA-S to androgens and estrogens, and then for metabolism into their inactive glucoronate and sulfated forms (FIG 1) . [24] steroidogenic enzymes have been found in human lacrimal glands and meibomian glands, as well as in corneal and conjunctival epithelial cells [39, 48] (Table 2 ). This suggests that tear producing tissues are able to produce sex hormones by intracrinology.
Possible local action of sex hormones produced by intracrine processes
Sex steroid receptor mRNAs have been found in human ocular surface tissues, as summarised in Table 1 . [43, 46, 47, 49] If these mRNAs are translated into proteins for sex steroid receptors, ocular surface tissues may be target sites for sex hormones and thus may be subject to the local action of these sex hormones. This supports intracrinology where sex hormones produced by intracrine processes exert their action locally within the same cells in which they were formed, before being metabolised locally. [50] The presence of mRNA alone for AR/ER/PR does not prove that these mRNAs are 
Gene regulation of ocular surface tissues by sex hormones
To establish whether sex steroids have sex-specific or antagonistic effects, studies have examined the influence of sex hormones on gene expression in epithelial cells of human meibomian glands and conjunctiva, and mice lacrimal glands and meibomian glands.
Sex hormone effect on gene expression is not limited to sex hormones produced by intracrine processes, therefore animal studies are used to support the two published human studies discussed in this section.
Sex appears to have a significant influence on gene expression in ocular surface tissues, affecting genes responsible for a broad range of processes. [51] [52] [53] However, the influence of sex on gene expression seems to be tissue-specific, with the majority of sex related differences in gene expression in the mouse meibomian gland being different to those in the mouse lacrimal gland. [54] The most highly expressed genes in human meibomian glands were unique to those in the human conjunctival epithelia, thus gene expression appears to be tissue-specific in humans as well as mice. Testosterone significantly altered the expression of thousands of genes in the lacrimal and meibomian glands of mice. [57] Interestingly, androgens impacted expression of genes involved in lipid metabolism and inhibition of keratinization in the mouse meibomian gland. [57] This agrees with the study of iHMGEC by Khandelwal et al. [53] Many of the biological and functional effects of androgens were the same in both males and females. [57, 59] Estrogen and progesterone also influenced expression of numerous genes in the mouse lacrimal gland [59] and meibomian gland. [60] However, their effects tended to be unique to those of androgens and the number of common genes was limited: estradiol, progesterone or a combination of both sex steroids significantly influenced less than 7% of genes controlled by androgens. The absence of estrogen, as a result of aromatase elimination, was associated with up/downregulation of thousands of genes in the mouse meibomian gland and lacrimal gland. [62, 63] More than 90% of these aromatase-linked genes were sex-specific which could explain the sex related differences of the mouse meibomian and lacrimal glands. [62, 63] There was no effect on tear volume in females, however a significant increase in tear volume in male mice was observed [62, 63] which suggests sex specific influences. Thus it appears that estrogen and aromatase play an important part in gene regulation in mice meibomian and lacrimal glands. [62, 63] However this effect appears to be sex specific.
In summary, there are very few published human studies of the effect sex hormones have on gene regulation in tear producing tissues. Mice studies suggest testosterone and estradiol influence expression of thousands of genes in the lacrimal gland and meibomian glands and that estradiol has contrasting effects to testosterone's stimulatory effect of meibomian glands. To understand the true nature of the role of sex hormones on human ocular surface tissues, further studies are required.
Measurement of sex hormone levels at the ocular surface
Many studies examining hormones are performed using animals; whilst these have their logistical benefits, including having larger sample sizes available and ability to control environmental conditions, the outcomes may not be generalizable to humans. Lower animal species, such as rats and rabbits, are different to humans since they lack intracrine synthesis of hormones. [23] There are many other variables which influence the effects of hormones, including species, sex, age, experimental procedure and strain of hormone used. [64] One difficulty of investigating local sex hormones in ocular tissues is the requirement for human tissue, which is not feasible in large scale studies. There are studies which use human ocular tissue following surgical removal, but these are rare and small scale. [46] Another option is to measure sex hormones in samples such as tears, meibum or through conjunctival impression cytology, which (although this approach may have other limitations) may be harvested non-surgically.
Sex hormone metabolites may enter the tear-film as a constituent of lacrimal gland secretions or within meibum, as a possible result of the holocrine nature of meibomian glands. [65, 66] This speculation is supported by the finding of 17β-Estradiol and progesterone in human tears (using immunoassay kits, in a preliminary study) at concentrations which correlated significantly with serum levels. [67] Due to low concentrations of hormones and the small sample volumes available from collection of tears, meibum or impression cytology, highly sensitive, reliable and repeatable methods are required. Liquid chromatography with tandem mass spectrometry (LC-MS/MS) is one such method and studies utilizing and developing these methods have begun to be published, [68] setting the standard for future studies.
They have the advantage of improved reproducibility, accuracy and sensitivity in comparison to immunoassays. [69] [70] [71] To our knowledge, mass spectrometry methods to measure sex hormones in human tears or meibum have not been published to date. A preliminary study managed to successfully detect pregnenolone, progesterone, DHEA, androstenedione and testosterone, as well as corticosteroid metabolites, in human tears using LC-MS/MS. [72] LC-MS and Gas chromatography -MS(GC-MS) methods were developed to detect 9 steroids (testosterone, androstenedione, cortisol, DHEA-S, DHEA, cortisone, β-estradiol, progesterone and androst-5-ene-3,17-diol) and serotonin in human tears, however levels were too low to reach the required sensitivity. [73] New instrumentation, with increased sensitivity, provides the possibility for future successful mass spectrometry measurement of sex hormones in human tears.
Sex hormone treatment and dry eye.
Due to the difficulties of measuring local levels of sex hormones, as discussed in section III B, the relationship between intracrine sex hormones and clinical signs or symptoms has not previously been investigated. Truong et al examined evidence for the role of systemic sex hormones in the aetiology of dry eye and the effect of systemic sex hormones on ocular function. [61] They concluded that androgens may have a beneficial impact on the lacrimal glands and meibomian glands, and that androgen deficiency is a contributing factor to dry eye aetiology. They suggested that the impact of estrogen is more uncertain, with studies finding contradictory effects of exogenous estrogen on ocular structures, shown by the unresolved relationship between HRT and dry eye signs and symptoms. [61] It is important to note that although studies thus far have looked at associations between serum sex hormones and dry eye, serum sex hormones represent only a small portion of sex hormones made in the body, since all estrogens and most androgens are produced and metabolized locally in peripheral tissues post-menopause. [22, 26, 30] Topical treatment with sex hormones may be a viable route of administration for local treatment of dry eye. Studies have used two different routes of topical administration:
cream applied to the eyelids or eye drops, summarized in Table 2 . In summary, eye drops and cream applied to the eyelids, supplemented with testosterone or DHEA have a beneficial effect on symptoms, tear stability and quantity. [75, 77, 80, 83] , [74, 78] However, evidence is weak with an absence of placebo controlled published studies which are required to improve our understanding of the possible application of topical androgens for clinical treatment of dry eye.
There are a very limited number of studies researching the effect of estradiol therapy on dry eye, including only two published controlled studies, one of which has many possible confounding factors. [88] Evidence seems to suggest that topical estradiol may be beneficial for the treatment of dry eye. This is in agreement with studies which found systemic estrogen treatment to improve dry eye, [87] [88] [89] [90] [91] [92] [93] but disagrees with studies which found systemic estrogen therapy to exacerbate dry eye. [94] [95] [96] Although systemic estrogen therapy has conflicting results, the limited results from studies of topical estradiol therapy (including preliminary studies) suggest a positive effect of topical treatment, which may be more associated with local synthesis of sex hormones. [24] Topical estrogen and androgen therapy appears to have a positive effect on signs and symptoms of dry eye; however published evidence is weak with the majority of studies being preliminary.
IV. SUMMARY
This review aimed to provide a comprehensive discussion focussed on the impact of local sex hormone synthesis on dry eye. It was necessary to discuss the wider topic of intracrinology before focussing on ocular structures. Despite the increase in knowledge of local hormone synthesis, much of the recent literature focusses on the effects of circulating, rather than local, sex hormones on signs or symptoms of dry eye. This is likely due to the relative ease of systemic measurement in comparison to local. Adapted from Labrie 2003. [30] Abbreviations: LH: Luteinising hormone, ACTH: adrenocorticotropin, DHEA: dehydroepiandrosterone.
